Skip to main content

AST to Platelet Ratio Index Calculator

AST to Platelet Ratio Index (APRI)

Understanding APRI

The AST to Platelet Ratio Index (APRI) is a simple, non-invasive tool used to assess liver fibrosis and cirrhosis, particularly in patients with chronic hepatitis C. It uses routine laboratory results - AST (Aspartate Aminotransferase) and platelet count - to help predict liver disease severity.

What is APRI?

APRI is calculated using the formula:

  • APRI = [(AST / AST Upper Limit of Normal) / Platelet Count] × 100

The result helps healthcare providers assess the likelihood of significant liver fibrosis or cirrhosis without requiring a liver biopsy.

Interpreting APRI Results

For Significant Fibrosis:

  • APRI < 0.5: Helps rule out significant fibrosis (high negative predictive value)
  • APRI > 0.7: Suggests significant fibrosis (sensitivity 77%, specificity 72%)
  • APRI > 1.5: Helps rule in significant fibrosis (high positive predictive value)

For Cirrhosis:

  • APRI < 0.5: Helps rule out cirrhosis (high negative predictive value)
  • APRI > 1.0: Suggests cirrhosis (sensitivity 76%, specificity 72%)
  • APRI > 2.0: High specificity for cirrhosis (specificity 91%, sensitivity 46%)

Values between these cutoffs fall in an indeterminate range and may require additional testing.

Clinical Significance

APRI is useful for:

  • Initial screening for liver fibrosis
  • Monitoring disease progression
  • Assessing need for further testing
  • Treatment decision-making

Important Considerations

  • Results should be interpreted by a healthcare professional
  • APRI is most validated in hepatitis C patients
  • Other causes of elevated AST or low platelets can affect results
  • Consider combining with other non-invasive tests (e.g., FibroTest) for better accuracy
  • Midrange values are less diagnostically helpful

When to Use APRI

APRI is particularly useful when:

  • Evaluating chronic liver disease
  • Screening for significant fibrosis
  • Monitoring disease progression
  • Assessing treatment response
  • Liver biopsy is not feasible

Limitations

This calculator:

  • Is not diagnostic on its own
  • May have reduced accuracy in certain conditions
  • Should be used alongside clinical judgment
  • May need confirmation with other tests

Tips for Accurate Results

  1. Use recent laboratory values
  2. Ensure correct units are selected
  3. Consider repeat testing if results are borderline
  4. Use alongside other clinical findings

Factors Affecting APRI

AST levels can be affected by

  • Liver disease
  • Muscle damage
  • Medications
  • Recent exercise
  • Other medical conditions

Platelet count can be affected by

  • Liver disease
  • Bone marrow conditions
  • Medications
  • Bleeding disorders
  • Infections

Clinical Applications

APRI is particularly valuable in:

  • Resource-limited settings
  • Initial screening
  • Monitoring known liver disease
  • Research studies
  • Treatment decision-making

Start calculating now to assess liver fibrosis risk!

References:

  1. Wai CT, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518-526.